Use of calcitonin gene-related peptide in the prevention and...

Details Use of calcitonin gene-related peptide in the prevention and... Use of calcitonin gene-related peptide in the prevention and...

A - Human Necessities

61

K

A61K 38/23 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2292902

The present invention relates to the use of calcitonin gene-related peptide (CGRP) in the prevention and alleviation of asthmatic symptoms. In contrast to other therapeutic agents now in use, CGRP combines both bronchoprotector and anti-inflammatory properties. Furthermore, it prevents both early and late phase bronchial responses associated with an asthma attack and its effective dose is small enough that undesirable haemodynamic side effects are not present.

Affiliated with

Also associated with

Rating

Use of calcitonin gene-related peptide in the prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of calcitonin gene-related peptide in the prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of calcitonin gene-related peptide in the prevention and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1465430